Selecta Biosciences (SELB) Environmental, Social & Governance (ESG) Data

Employees

Data from SEC filings

Employee count

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Air Biodegradable Environment Environmental Materials Nature Offset Package Packaging Pandemic Raw Materials Regenerative Toxic Waste Wind Access African American Asian Attrition Benefits Black California Consumer Privacy Act Community Culture Customer Cybersecurity Data Privacy Death Demographic Disability Diversity Diversity and Inclusion Employee Employee Engagement Engagement Ethnic Ethnicity Gender General Data Protection Regulation Health and Safety Health Care Healthcare Hire Hiring Hispanic Human Capital Injuries Injury Labor Condition Latinx LGBTQ Pay Equity Perquisites Privacy Recall Recruit Recruitment Reimbursement Retention Retirement Safety Satisfaction Skill Skilled Skills Social Society Supplier Supply Chain Talent Training Union Volunteer Women Workers Workforce Anti-corruption Antitrust Assessment Assurance Attorneys General Audit Board Evaluation Bonus Bribery Chronic Class Action Lawsuit Classified Claw Back Clawback Commitment Conflict of Interest Controversy Corporate Governance Corporate Purpose Department of Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Independence Independent Innovation Innovative Investigation Lawsuit Lead Independent Director Leadership Litigation Long-term Majority Mission Oversee Oversight Perquisite Plaintiff Pledging Purpose R&D Recoup Reputation Reputational Research and Development Responsibility Responsible Self-evaluation Stewardship Strategy Targets Tax Tenure Transparency Transparent Voting Rights

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On June 18, 2021, Selecta Biosciences, Inc. (the “Company”) held its Annual Meeting of Stockholders. A total of 76,356,811 shares of the Company’s common stock were present electronically or represented by proxy at the meeting, representing approximately 67.46% of the Company’s outstanding common stock as of the April 21, 2021 record date. The following are the voting results for the proposals considered and voted upon at the meeting, all of which were described in the Company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on April 29, 2021.